Get the Stockscreener App
0.1913
4.87%
-0.0098
After Hours:
.19
-0.0013
-0.68%
VolitionRX Ltd stock is traded at $0.1913, with a volume of 140.42M.
It is down -4.87% in the last 24 hours and down -21.34% over the past month.
VolitionRX Limited, a life sciences company, engages in the development of blood tests to help diagnose a range of cancers worldwide. The company develops 39 epigenetic Nu.Q blood assays based on its Nucleosomics biomarker discovery platform. VolitionRX Limited is based in Singapore.
See More
Previous Close:
$0.2011
Open:
$0.235
24h Volume:
140.42M
Relative Volume:
14.21
Market Cap:
$25.93M
Revenue:
$1.47M
Net Income/Loss:
$-23.06M
P/E Ratio:
-0.8412
EPS:
-0.2274
Net Cash Flow:
$-19.64M
1W Performance:
-4.35%
1M Performance:
-21.34%
6M Performance:
-68.12%
1Y Performance:
-65.40%
1-Day Range:
$0.1859
$0.2386
1-Week Range:
$0.171
$0.2386
52-Week Range:
$0.17
$0.94
VolitionRX Ltd Stock (VNRX) Company Profile
Name
VolitionRX Ltd
Sector
Industry
Phone
646 650 1351
Address
No. 24-05 Shaw Centre, 1 Scotts Road, Singapore, TX
Compare VNRX vs TMO, DHR, IDXX, A, WAT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VNRX
VolitionRX Ltd
|
0.1913 | 27.26M | 1.47M | -23.06M | -19.64M | -0.2274 |
TMO
Thermo Fisher Scientific Inc
|
490.77 | 182.14B | 44.56B | 6.72B | 6.29B | 17.74 |
DHR
Danaher Corp
|
187.15 | 134.43B | 24.57B | 3.60B | 5.26B | 5.051 |
IDXX
Idexx Laboratories Inc
|
575.72 | 45.40B | 4.30B | 1.06B | 1.04B | 13.08 |
A
Agilent Technologies Inc
|
112.98 | 32.27B | 7.07B | 1.29B | 993.00M | 4.5355 |
WAT
Waters Corp
|
302.32 | 29.62B | 3.17B | 642.63M | 516.49M | 10.77 |
VolitionRX Ltd Stock (VNRX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-08-25 | Initiated | H.C. Wainwright | Buy |
| Feb-01-23 | Downgrade | The Benchmark Company | Buy → Hold |
| Feb-17-22 | Resumed | Cantor Fitzgerald | Overweight |
| Mar-10-21 | Initiated | Cantor Fitzgerald | Overweight |
| May-16-18 | Initiated | Maxim Group | Buy |
| May-14-18 | Reiterated | The Benchmark Company | Buy |
| Sep-07-16 | Reiterated | Rodman & Renshaw | Buy |
| Feb-01-16 | Initiated | Rodman & Renshaw | Buy |
View All
VolitionRX Ltd Stock (VNRX) Latest News
VolitionRx Limited Schedules Full Fiscal Year 2025 Earnings Conference Call and Business Update - Yahoo Finance Singapore
VolitionRx Limited (VNRX) Stock: Rallies on Promising Multi-Cancer Early Detection Breakthrough - parameter.io
Blood test detects 95% of stage I and II cancers in blinded study - Stock Titan
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
VNRX Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
VolitionRx (NYSE: VNRX) CCO shares withheld and cancelled for RSU taxes - Stock Titan
Tax withholding reduces VolitionRx (NYSE: VNRX) secretary’s share count - Stock Titan
VolitionRx (VNRX) CSO uses 5,310 shares to cover tax bill - Stock Titan
VolitionRx (VNRX) GC has 7,003 shares cancelled for tax withholding - Stock Titan
In today's session, these stocks are experiencing unusual volume. - ChartMill
VNRX Receives Unchanged 'Buy' Rating from D. Boral Capital | VNR - GuruFocus
VolitionRX Ltd (VNRX) Stock Price, Quote, News & History - Benzinga
VolitionRx Limited (VNRX) Stock: Jumps on World-First Cancer DNA Isolation Breakthrough - parameter.io
These stocks are the most active in today's session - ChartMill
Stock Market Volume Leaders: Nasdaq, NYSE, and NYSE American Trading ActivityNews and Statistics - IndexBox
Aug Drivers: What is the cash position of VolitionRx Limited2026 Biggest Moves & High Accuracy Swing Trade Signals - baoquankhu1.vn
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
VolitionRx (VNRX) Stock Soars 70% on Revolutionary Cancer DNA Discovery - Blockonomi
VolitionRx (VNRX) Stock Soars 70% on Liquid Biopsy Breakthrough - parameter.io
VolitionRx (VNRX) Stock Soars 70% on Revolutionary Cancer DNA Detection Method - MoneyCheck
VolitionRx (VNRX) Stock Surges 70% After Cancer DNA Breakthrough - CoinCentral
New liquid biopsy from VolitionRx finds 49 of 49 cancers in early study - Stock Titan
VNRX Stock Price, Quote & Chart | VOLITIONRX LTD (NYSEARCA:VNRX) - ChartMill
VolitionRx Ltd Stock (ISIN: US92852X1037) Faces Prolonged Uncertainty Amid Diagnostics Stagnation - AD HOC NEWS
VolitionRX (VNRX) Stock Price, News & Analysis - MarketBeat
VolitionRX: Navigating the Path from Innovation to Market Adoption () - aktiencheck.de
VolitionRx announces automated Nu.Q Vet Cancer Test with Fujifilm Vet Systems - Yahoo Finance
VolitionRx shares jump as feline cancer blood test delivers strong accuracy results - MSN
VolitionRx (VNRX) Completes Key Phase for Nu.Q Vet Cancer Test i - GuruFocus
Volition announces first ever automated Nu.Q® Vet cancer test with Fujifilm Vet Systems - marketscreener.com
Automated cancer screening test set for Japan’s 7M pet dogs - Stock Titan
Tax withholding on VolitionRx (VNRX) shares for officer via RSU settlement - Stock Titan
VolitionRx (VNRX) CCO covers tax bill via 2,283-share cancellation - Stock Titan
Tax withholding trims VolitionRx (VNRX) GC Nicholas Plummer’s shares - Stock Titan
VNRX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
AIFF PE Ratio & Valuation, Is AIFF Overvalued - Intellectia AI
VolitionRx issues shares to satisfy debt obligations and completes private placement - Investing.com
VNRX SEC FilingsVolitionrx 10-K, 10-Q, 8-K Forms - Stock Titan
VolitionRx (VNRX) grants CCO 149,000 RSUs in lieu of cash pay - Stock Titan
Ethel Rubin receives 178,000 RSU award at VolitionRx Ltd (VNRX) - Stock Titan
Executive at VolitionRx (VNRX) awarded 142,000 RSUs in lieu of cash pay - Stock Titan
VOLITIONRX (VNRX) CFO awarded 202,000 RSUs in lieu of cash pay - Stock Titan
119,000 RSUs granted to VolitionRx (VNRX) secretary in lieu of cash pay - Stock Titan
VolitionRx (VNRX) grants 187,000 RSUs to General Counsel Plummer - Stock Titan
[Form 4] VOLITIONRX LTD Insider Trading Activity - Stock Titan
VolitionRx (VNRX) executive receives 173,000 RSUs instead of cash pay - Stock Titan
VolitionRx (VNRX) grants CSO 149,000 RSUs instead of cash - Stock Titan
Director at VolitionRx (VNRX) granted 178,000 RSUs in lieu of cash - Stock Titan
VolitionRx advances cancer tests, expects French reimbursement By Investing.com - Investing.com Australia
VolitionRx Reports Clinical and Commercial Progress Across Cancer Detection and Sepsis Monitoring Platforms - citybuzz -
VolitionRx advances cancer tests, expects French reimbursement - Investing.com
VolitionRX Ltd Stock (VNRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.19%
0.04%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):